Physician profile
Eric Bernstein
NPI 1508978487
$12,248.71
in general payments reported to CMS, 2019-2025
55 companies · $1,349 in 2025
The $1,349 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,291 · 2020: $1,582 · 2021: $1,350 · 2022: $1,962 · 2023: $1,781 · 2024: $1,935 · 2025: $1,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,064.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,925.88 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $1,794.83 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,273.74 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $1,035.37 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $770.14 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Pfizer INC. | $663.12 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $544.01 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Allergan, INC. | $472.60 | 2019-2022 | |
| Glaxosmithkline, LLC. | $457.68 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $433.40 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $367.14 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $295.45 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $255.42 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $212.69 | 2019-2023 | Xarelto |
| Amarin Pharma, INC. | $183.53 | 2019-2023 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.